Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide

Journal of Cellular Physiology

Volumn 173, Issue 1, 1997, Pages 73-83

  Wang, Xiao Shu ^a   Gruenstein, Eric ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; MEMBRANE RECEPTOR; PHOSPHOLIPASE C;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TANDEM REPEAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; APOLIPOPROTEINS E; CADMIUM; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELLS, CULTURED; COBALT; CYTOPLASM; ESTRENES; FLUORESCENT DYES; FURA-2; LDL-RECEPTOR RELATED PROTEIN 1; MOLECULAR SEQUENCE DATA; NEURONS; PEPTIDE FRAGMENTS; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN;

ANIMALIA;

EID: 0030763447     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199710)173:1<73::AID-JCP9>3.0.CO;2-G     Document Type: Article

References (51)

1. Avila, E.M., Holdsworth, G., Sasaki, N., Jackson, R.L., and Harmony, J.A.K. (1982) Apoprotein E suppreses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J. Biol. Chem., 257:5900-5909.
2. Benzing, W.C., and Mufson, E.J. (1995) Apolipoprotein E immunoreactivity within neurofibrillary tangles: Relationship to Tau and PHF in Alzheimer's disease. Exp. Neurol., 132:162-171.
3. Boyles, J.K., Zoellner, C.D., Anderson, L.J., Kosik, L.M., Pitas, R.E., Weisgraber, K.H., Hui, D.Y., Mahley, R.W., Gebicke-Haerter, P.J., Ignatius, M.J., and Shooter, E.M. (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest., 83:1015-1031.
4. Carlsson, J., Armstrong, V.W., Reiber, H., Felgenhauer, K., and Seidel, D. (1991) Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin. Chim. Acta, 196:167-176.
5. Clay, M.A., Anantharamaiah, G.M., Mistry, M.J., Balasubramaniam, A., and Harmony, J.A.K. (1995) Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry, 34:11142-11151.
6. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., and Pericak-Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261:921-923.
7. Crutcher, K.A., Clay, M.A., Scott., S.A., Tian, X., Tolar, M., and Harmony, J.A.K. (1994) Neunte degeneration elicited by apolipoprotein E peptides. Exp. Neurol., 130:120-126.
8. Cunningham, A.M., Ryugo, D.K., Sharp, A.H., Reed, R.R., Snyder, S.H., and Ronnett, G.V. (1993) Neuronal inositol 1,4,5-trisphosphate receptor localized to the plasma membrane of olfactory cilia. Neuroscience, 57:339-352.
9. Das, H.K., McPherson, J., Bruns, G.A.P., Karathanasis, S.K., and Breslow, J.L. (1985) Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem., 260:6240-6247.
10. Dyer, C.A., and Curtisss, L.K. (1988) Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis. J. Biol. Chem., 263:10965-10973.
11. Dyer, C.A., and Curtiss, L.K. (1991) A synthetic peptide mimic of plasma appolipoprotein E that binds the LDL receptor. J. Biol. Chem., 266:22803-22806.
12. Dyer, C.A., Smith, R.S., and Curtiss, L.K. (1991) Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J. Biol. Chem., 266:15009-15015.
13. Dyer, C.A., Cistola, D.P., Parry, G.C., and Curtiss, L.K. (1995) Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor. J. Lipid Res., 36:80-88.
14. Elshoubragy, N.A., Liao, W.S., Mahely, R.W., and Taylor, J.M. (1985) Apolipoprotein E mRNA is aboudant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA, 82:203-207.
15. Grill, R.J., Jr., and Pixley, S.K. (1993) 2-Mercaptoethanol is a survival factor for olfactory, cortical and hippocampal neurons in short-term dissociated cell culture. Brain Res., 613:168-172.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260:3440-3450.
17. Handelmann, G.E., Boyles, J.K., Weisgraber, K.H., Mahley, R.W., and Pitas, R.E. (1992) Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res., 31:1677-1688.
18. Holtzman, D.M., Pitas, R.E., Kilbridge, J., Nathan, B., Mahley, R.W., Bu, G., and Schwartz, A.L. (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite out-growth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA, 92:9480-9484.
19. Hui, D.Y., Harmony, J.A.K., Innerarity, T.L., and Mahley, R.W. (1980) Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. J. Biol. Chem., 255:11775-11781.
20. Ignatius, M.J., Gebicke-Harter, P.J., Skene, J.H.P., Schilling, J.W., Weisgraber, K.H., Mahley, R.W., and Shooter, E.M. (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA, 83:1125-1129.
21. Kounnas, M.Z., Argraves, W.S., and Strickland, D.K. (1992) The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330. J. Biol. Chem., 267:21162-21166.
22. 3-activated calcium-permeable channels in the inside-out patches of cultured cerebellar Purkinje cells. Biochem. Biophys. Res. Commun., 199:1128-1135.
23. Mahley, R.W. (1988) Apolipoprotien E: Cholesterol transport protein with expanding role in cell biology. Science, 240:622-630.
24. Marcos, A.M., Tolar, M., Harmony, J.A.K., and Crutcher, K.A. (1996) A thrombin cleavage fragment of apolipoprotein E exhibits isoform specific neurotoxicity. NeuroReport, 15:2529-2532.
25. 2+ entry. Mol. Neurobiol., 12:163-180.
26. 2+-homeostasis in central neurons and astrocytes by apolipoprotein E and bA4. Soc. Neurosci. Abstr., 22:257.
27. Murphy, T.H, Blatter, L.A., Wier, W.G., and Baraban, J.M. (1992) Spontaneous synchroonous synaptic calcium transients in cultured cortical neurons. J. Neurosci., 12:4834-4845.
28. Nagy, Z., Esiri, M.M., Jobst, K.A., Johnston, C., Litchfield, S., Sim, E., and Smith, A.D. (1995) Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience, 69:757-761.
29. Namba, Y., Tomonaga, M., Kavwasaki, H., Otomo, E., and Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and Kuru plaque amyloid in Creuzfeldt-Jakob disease. Brain Res., 541:163-166.
30. Nathan, B.P., Bellosta., S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W., and Pitas, R.E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264:850-852.
31. Olaisen, B., Teisberg, P., and Gedde-Dahl, T., Jr. (1982) The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man. Hum. Genet., 62:233-236.
32. Pepe, M.G., and Curtiss, L.K. (1986) Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDH-In. J. Immunol., 136:3716-3723.
33. Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D.Y., and Weisgraber, K.H. (1987) Lipoproteins and their receptors in the central nervous system: Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. J. Biol. Chem., 262:14352-14360.
34. Putney, J.W., Jr., and Bird, G.S. (1994) The inositol phosphate-calcium signaling system in nonexcitable cells. Endocr. Rev., 14:610-631.
35. Reyland, M.E., Gwynne, J.T., Forgez, P., Prack, M.M., and Williams, D.L. (1991) Expression of the human apolipoprotein E gene suppresses steroidogenesis in mouse Y1 adrenal cells. Proc. Natl. Acad. Sci. USA, 88:2375-2319.
36. Richey, P.L., Siedlak, S.L., Smith, M.A., and Perry, G. (1995) Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: Implications for disease pathogenesis. Biochem. Biophys. Res. Commun., 208:657-663.
37. Saunders, A.M., Strittmatter, W.J., Schmechel, S., Geroge-Hyslope, St.P.H., Pericak-Vance, M..A., Joo, S.H., Rosi, B.L., Gusella, J.F., Carpper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A.D. (1993) Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43:1467-1472.
38. Shore, V.G., and Shore, B. (1973) Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry, 12:502-507.
39. 3 rat pituitary cells. Endocrinology, 131:1883-1888.
40. Snipes, G.J., McGuire, C.B., Norden, J.J., and Freeman, J.A. (1986) Nerve injury stimulates the secretion of apolipoprotein E by non-neuronal cells. Proc. Natl. Acad. Sci. USA, 83:1130-1134.
41. Sparrow, J.T. (1976) An improved polystyrene support for solid phase peptide synthesis. J. Org. Chem., 41:1350-1353.
42. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., and Roses, A.D. (1993) Apolipoprotein E: High avidity binding to b-amyloid and increased frequency of type-4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90:1977-198.
43. Tensen, C.P., van Kesteren, E.R., Planta, R.J., Cox, K.J.A., Burke, J.F., van Heeriskhuizen, H., and Vreugdenhil, E. (1994) A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction. Proc. Natl. Acad. Sci. USA, 91:4816-4820.
44. 2+ in the cell cycle in human fibroblasts: Transitions between G1 and G0 and progression into S phase. Mol. Biol. Cell., 4:293-302.
45. Wang, X., Ciraolo, G., Morris, R., and Gruenstein, E. (1997) Identification of a neuronal endocytic pathway activated by an apolipoprotein E (apoE) receptor binding peptide. Brain Res. (In press).
46. Weisgraber, K.H. (1994) Apolipoprotein E: Structure-function relationships. Adv. Protein Chem., 45:249-302.
47. Weisgraber, K.H., Roses, A.D., and Strittmatter, W.J. (1994) The role of apolipoprotein in the nervous system. Curr. Opin. Lipid, 5:110-116.
48. Wisnewski, T., and Frangione, B. (1992) Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett., 135:235-238.
49. Wustenberg, F., Berlin, K., Scharnagl, H., März, W., Ohm, T.G., and Müller, W. 1996. Differentially elevated intracellular calcium levels by apoE-isoforms in the presence of bA4-amyloid. Soc. Neurosci. Abstr., 22:257.
50. Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X., and Hirai, S. (1994) Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Acta Neuropathol., 88:413-419.
51. 2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J. Biol. Chem., 267:13830-13835.